The obstacles to personalized medicine include the high cost of precision cancer drugs, the challenge of getting patients fully engaged in their own care, a lack of mature, universal interoperability, and questions about the effectiveness of precision medicine interventions.
In this presentation, industry thought-leader John Halamka, MD, who co-authored the book, Realizing the Promise of Precision Medicine, will address these issues and conclude with a personal story about his wife, Kathy Halmaka, who was successfully treated for breast cancer with a personalized approach that included using the digital technologies SHRINE, i2b2, and Clinical Query 2.
· The cost effectiveness of personalized medicine is a work in progress.
· Carefully selected digital technology will help get patients engaged in personalized care.
· Software suites and clinical research databases are already demonstrating the value of precision medicine.